News Focus
News Focus
Post# of 597163
Next 10
Followers 988
Posts 187589
Boards Moderated 5
Alias Born 02/01/2007

Re: TheFinalCD post# 513732

Wednesday, 06/13/2012 11:45:15 AM

Wednesday, June 13, 2012 11:45:15 AM

Post# of 597163
GNBT is getting closer to a cancer vaccine, so if you are in it, click on the 2 links below

GNBT OncUView.tv Interviews Featuring the Antigen Express AE37

Generex Announces OncUView.tv Interviews Featuring the Antigen Express AE37 Breast Cancer Vaccine at ASCO 2012

WORCESTER, Mass. and TORONTO , June 13, 2012 /PRNewswire/ -- Generex Biotechnology Corporation (OTCBB: GNBT) announced today that two interviews conducted at the 2012 Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago earlier this month featuring the on-going Phase II clinical trial of the Antigen Express AE37 immunotherapeutic breast cancer vaccine are now available for online viewing at OncUView.tv.
Dr. Timothy Vreeland , MD of the San Antonio Military Medical Center made the June 4, 2012 podium presentation at ASCO 2012 of the abstract entitled "From bench to bedside: The use of the li-Key technology to improve helper peptides for clinical use in cancer vaccines" during the session on Developmental Therapeutics — Clinical Pharmacology and Immunotherapy. For this abstract, Dr. Vreeland was recognized with a 2012 Conquer Cancer Foundation of ASCO Merit Award bestowed by the Conquer Cancer Foundation of the American Society of Clinical Oncology and the 2012 Scientific Program Committee. The interview of Dr. Vreeland can be viewed at:
http://www.oncuview.tv/Videos/TabId/79/VideoId/452/Breast-Cancer-And-2012-ASCO-Merit-Award-Winner-Interview-With-Timothy-Vreeland-MD-At-ASCO-2012.aspx

Dr. Elizabeth A. Mittendorf , MD is an Assistant Professor in the Department of Surgical Oncology at the University of Texas MD Anderson Cancer Center and the Principal Investigator for the on-going Phase II clinical trial of the Antigen Express AE37 immunotherapeutic breast cancer vaccine. The interview of Dr. Mittendorf, where she discusses the AE37 trial results presented at ASCO 2012 and the immunotherapeutic treatment of breast cancer generally, can be viewed at:
http://www.oncuview.tv/Videos/TabId/79/VideoId/440/Breast-Cancer-Interview-With-Elizabeth-Ann-Mittendorf-MD-At-ASCO-2012.aspx

All material posted by langlui is purely my opinion and is not buy or sell recommendations. Do your DD, buy and sell based on that DD.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today